Skip to content

Autonomic Nervous System Function - Hypertension

Perceived Stress and Patterns of Autonomic Function: a Protocol Development Study

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05312996
Enrollment
30
Registered
2022-04-06
Start date
2021-10-01
Completion date
2023-10-26
Last updated
2023-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The Life University Center for Chiropractic Research is conducting a research study to better understand the physiological differences, in terms of Autonomic nervous system function, between individuals with Hypertension and control individuals with out hypertension. Data will be gathered using Heart Rate Variability (HRV), and Galvanic Skin Response (GSR). A series of tests will be conducted to elicit Autonomic Nervous system responses. These tests include Cold Face Test (mammalian dive reflex), Cold Pressor test, Sit to stand, and the Valsalva maneuver.

Detailed description

The objective of the study is to ascertain the level of autonomic health in persons with hypertension versus a healthy population. Further, via the implemented protocol, the study will attempt to develop a sequence of autonomic nervous system tests to be used in future studies and clinical settings

Interventions

OTHERHeart Rate Variability

Caretaker Heart Rate Variability ECG wrist monitor and chest patch.

OTHERGalvanic Skin Response (Biopac)

Galvanic Skin Response- measuring autonomic response-via perspiration

Sponsors

Life University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Participants will be included in the hypertension group if they present with the following: * Hypertension, defined as: * Self-reported or previously diagnosed with elevated resting state blood pressure (120-129 systolic and less than 80 mmHg diastolic) or stage 1 hypertension with a blood pressure of Systolic between 130- and 139-mm Hg with a diastolic of 80-89 mmHg. * Or medically diagnosed and managed stage 2 hypertension with blood pressure of Systolic between 140- and 159-mm Hg or diastolic 90 and 99 mm * between the ages of 18-65 * Able to wear a monitor on their right wrist. * Able to wear a pulse oximeter on their left hand. Participants will be included in the healthy group if they present with the following: * between the ages of 18-65 * Able to wear a monitor on their right wrist. * Able to wear a pulse oximeter on their left hand.

Design outcomes

Primary

MeasureTime frameDescription
Heart Rate VarabilityThrough study completion, an average of 1 yearCaretaker Heart Rate Variability (HRV) Electrocardiogram (ECG) wrist monitor and chest patch.
Galvanic Skin ResponseThrough study completion, an average of 1 yearGalvanic Skin Response- measuring autonomic response-via perspiration

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026